This page has only limited features, please log in for full access.

Unclaimed
Ingyu Lee
Graduate School of Biomedical Convergence, College of Medicine, Chungbuk National University, 1 Chungdae-ro, Seowon-Gu, Cheongju 28644, Chung-cheongbuk-do, Korea

Basic Info

Basic Info is private.

Honors and Awards

The user has no records in this section


Career Timeline

The user has no records in this section.


Short Biography

The user biography is not available.
Following
Followers
Co Authors
The list of users this user is following is empty.
Following: 0 users

Feed

Journal article
Published: 07 April 2021 in Sustainability
Reads 0
Downloads 0

Due to the high risk in development process, the bio-pharmaceutical industry has transformed itself into an open innovation framework in order to overcome economic risk. This study examines the relationship between outbound open innovation and financial performance in bio-pharmaceutical industry. Specifically, this study extends knowledge-based view to link the open innovation performance and licensor’s sustainability. In order to provide empirical evidence, this study uses econometric methodology with several databases including bio-pharmaceutical firms. The analysis shows firm’s desorptive capabilities have a significant effect on financial performance, confirming the application of knowledge capacity framework. The result of the study can suggest the way how the licensors can maintain the sustainability of competitiveness in bio-pharmaceutical industry.

ACS Style

Eungdo Kim; Ingyu Lee; Hongbum Kim; Kwangsoo Shin. Factors Affecting Outbound Open Innovation Performance in Bio-Pharmaceutical Industry-Focus on Out-Licensing Deals. Sustainability 2021, 13, 4122 .

AMA Style

Eungdo Kim, Ingyu Lee, Hongbum Kim, Kwangsoo Shin. Factors Affecting Outbound Open Innovation Performance in Bio-Pharmaceutical Industry-Focus on Out-Licensing Deals. Sustainability. 2021; 13 (8):4122.

Chicago/Turabian Style

Eungdo Kim; Ingyu Lee; Hongbum Kim; Kwangsoo Shin. 2021. "Factors Affecting Outbound Open Innovation Performance in Bio-Pharmaceutical Industry-Focus on Out-Licensing Deals." Sustainability 13, no. 8: 4122.